M
Marie Paule Kieny
Researcher at French Institute of Health and Medical Research
Publications - 81
Citations - 7141
Marie Paule Kieny is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Vaccination & Live attenuated influenza vaccine. The author has an hindex of 36, co-authored 81 publications receiving 6237 citations. Previous affiliations of Marie Paule Kieny include World Health Organization.
Papers
More filters
Journal ArticleDOI
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Ana Maria Henao-Restrepo,Anton Camacho,Ira M. Longini,Conall H. Watson,W. John Edmunds,Matthias Egger,Matthias Egger,Miles W. Carroll,Natalie E. Dean,Ibrahima Dina Diatta,Moussa Doumbia,Bertrand Draguez,Sophie Duraffour,Godwin Enwere,Rebecca F. Grais,Stephan Günther,Pierre Stéphane Gsell,Stefanie Hossmann,Sara Sofie Viksmoen Watle,Mandy Kader Kondé,Sakoba Keita,Souleymane Kone,Eewa Kuisma,Myron M. Levine,Sema Mandal,Thomas Mauget,Gunnstein Norheim,Ximena Riveros,Aboubacar Soumah,Sven Trelle,Andrea S. Vicari,John-Arne Røttingen,Marie Paule Kieny +32 more
TL;DR: The evidence from all 117 clusters showed that no cases of Ebola virus disease occurred 10 days or more after randomisation among all immediately vaccinated contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa.
Journal ArticleDOI
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Ana Maria Henao-Restrepo,Ira M. Longini,Matthias Egger,Matthias Egger,Natalie E. Dean,W. John Edmunds,Anton Camacho,Miles W. Carroll,Miles W. Carroll,Moussa Doumbia,Bertrand Draguez,Sophie Duraffour,Godwin Enwere,Rebecca F. Grais,Stephan Günther,Stefanie Hossmann,Mandy Kader Kondé,Souleymane Kone,Eeva Kuisma,Eeva Kuisma,Myron M. Levine,Sema Mandal,Gunnstein Norheim,Ximena Riveros,Aboubacar Soumah,Sven Trelle,Andrea S. Vicari,Conall H. Watson,Sakoba Keita,Marie Paule Kieny,John-Arne Røttingen,John-Arne Røttingen,John-Arne Røttingen +32 more
TL;DR: The results of this interim analysis indicate that rVSV-ZEBOV might be highly efficacious and safe in preventing Ebola virus disease, and is most likely effective at the population level when delivered during an Ebola virus Disease outbreak via a ring vaccination strategy.
Journal ArticleDOI
Cost-effectiveness thresholds: pros and cons
Melanie Y Bertram,Jeremy A. Lauer,Kees de Joncheere,Tessa Tan-Torres Edejer,Raymond Hutubessy,Marie Paule Kieny,Suzanne Hill +6 more
TL;DR: Although cost–effectiveness ratios are undoubtedly informative in assessing value for money, countries should be encouraged to develop a context-specific process for decision-making that is supported by legislation, has stakeholder buy-in, for example the involvement of civil society organizations and patient groups, and is transparent, consistent and fair.
Journal ArticleDOI
The 2009 A (H1N1) influenza virus pandemic: A review.
TL;DR: The need for an increased surveillance of influenza virus circulation in swine is outlined, and all currently registered vaccines were found to be safe and to elicit potentially protective antibody responses after the administration of a single dose of vaccine.